-
We test everything on a one- and a three-year cycle. And you want to stress-test a model, and the three-year test usually does that because you have a growth and value bias. You have different interest rate environments.
-
I sell these intermediate bond portfolios for people that can't go to stocks.
-
Open the borders to willing workers from any and all nations. They will create businesses that pay taxes, especially payroll taxes to fund Medicare and Social Security benefits of retiring baby boomers.
-
We call it the zigzag theory. You want to find something that zigs and something that zags and blend them together to get a better combined performance.
-
What we do is we test what works on Wall Street. And sometimes it is earnings momentum, and sometimes it's earnings surprises. Sometimes it's price-to-sales cash flow, and then we put together our stock selection models.
-
I simply can't buy as much of some stocks such as Detection Systems or United Education & Software as I'd like because there just aren't all that many shares available.
-
One of the things that launched the strength in biotech is when the pharmaceutical industry itself got a little slow.
-
I want attractive stocks that will benefit from persistent institutional buying pressure.
-
There's a lot of companies that profit from a weak dollar.
-
Since we try and take a fairly buy-and-hold approach to our newsletter portfolios and don't sell at every whipsaw, we want to have a mix of stocks that will perform at both ends of the oscillation.
-
There is a substantial correlation between an election year and how the market finishes.
-
If you are a short-term trader, you have the right to come and go from our funds.
-
I still love the semiconductor industry.
-
I've been investing in the stock market for 27 years and, within that time, have helped investors beat the market nearly four to one.